The National Institutes of Health Small Business Innovation Research (SBIR) Program has awarded a grant of more than $400,000 to researchers from Capital Health Cancer Center in Pennington, New Jersey, and JBS Scientific Inc. in Doylestown, Pennsylvania. The grant
Nicholas A. Meanwell, PhD, former pharmaceutical industry scientist and executive and now distinguished professor at the Baruch S. Blumberg Institute, has been selected as the recipient of the 2024 Antonin Holý Award by the International Society for
A special issue of a major drug development journal published recently honors Nicholas A. Meanwell, PhD, a former pharmaceutical industry scientist and executive who now is a distinguished professor at the Baruch S. Blumberg Institute. The journal’s
Robert Christmas, a longtime bank executive in the Philadelphia area, has been named chief operating officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC). Louis P. Kassa III, chief executive officer of the three nonprofit organizations and president of the PABC, said: “Bob has
Collaboration will help attract talent, new capital and resources to region’s biomedical research pipeline. The Wistar Institute has formed a new strategic collaboration with the Pennsylvania Biotechnology Center (PABC) and the Baruch S. Blumberg Institute to accelerate the advancement of “bench to bedside”
MERLIN Biotech CEO Randall N. Hyer delivers details – and a comprehensive strategic plan – for the company’s promising mRNA technology MERLIN Biotech, a spinout from the Baruch S. Blumberg Institute, presented its first asset last month
There currently is no effective treatment for yellow fever, which kills thousands of people every year. Doylestown, Pa., Jan. 17, 2023 – The Baruch S. Blumberg Institute has been awarded a one-year contract by the National Institute
By Damon Williams, Bucks County Courier Times Photo by Nur B. Adam, Bucks County Courier Times Timely state investment and cutting-edge laboratories and support has positioned the Doylestown-based Pennsylvania Biotechnology Center as crucial cog in Bucks County's
May 6, 2022 Thomas E. Shenk, PhD, has joined the Blumberg Institute’s faculty as Distinguished Professor of Experimental Therapeutics and Translational Medicines. Dr. Shenk is Emeritus James Elkins Professor of Life Sciences in molecular biology at Princeton
